Regulating nuclear export or restoring NPC function via modulation of the cytoskeleton-nucleus connection could represent feasible therapeutic strategies for multiple forms of ALS and other neurodegenerative diseases beyond ALS. The gene discussed is NPC1; the disease is neurodegenerative disease.